PART1 and posterior cortical atrophy: PDE4D7 and PART1 have previously been proposed as separate biomarkers for PCa [1,11], however measuring these two genes in combination, or alongside others identified here with correlative expression, could further enhance the specificity of these biomarkers in prognostic approaches.